Press "Enter" to skip to content

New patent expiration for Andrx Labs drug FORTAMET

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Andrx Labs drug FORTAMET

Annual Drug Patent Expirations for FORTAMET
Annual Drug Patent Expirations for FORTAMET

Fortamet is a drug marketed by Andrx Labs Llc and is included in one NDA. It is available from two suppliers. There are two patents protecting this drug and one Paragraph IV challenge.

Drug patent litigation for FORTAMET.

This drug has fifteen patent family members in nine countries.

The generic ingredient in FORTAMET is metformin hydrochloride. Two suppliers are listed for this compound. Additional details are available on the metformin hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent expiration for Andrx Labs drug FORTAMET
Find your next blockbuster

Get accurate and timely intelligence — in just a few clicks

✓ Free trial

✓ No credit card

 

DrugPatentWatch - Make Better Decisions